U.S. Specialized REITs Stock News

Brinker International’s stock has delivered an exceptional three year return, yet the current intrinsic value estimate from a Discounted Cash Flow (DCF) model and the earnings based multiples both point to a share price that now looks roughly in line with fundamentals rather than obviously cheap. Over the past three years, Brinker International has returned very close to 5x for shareholders, which puts extra focus on whether the current price still leaves much room for error. Future cash...

Byline Bancorp stock has delivered an 83.6% return over the past three years, yet its current valuation checks send a mixed signal about how much upside might still be on the table. The intrinsic value estimate from the Excess Returns model points to the shares trading at a meaningful discount, while the broader scorecard and market multiples suggest pricing is closer to fair than outright cheap. Byline Bancorp has returned 83.6% over three years, which puts recent gains front and center in...

ABM Industries has gained 13.7% year to date, while a fresh Discounted Cash Flow (DCF) intrinsic value estimate points to the stock trading at a steep discount of about 49.7% to that calculation, which sits alongside a broader set of checks that flag a more mixed picture. Year to date the stock is up 13.7%, which means recent buyers are already sitting on a solid gain before considering what the current price implies about the future. The new robotics pilot at LaGuardia Terminal B can...

Service prices are still rising at 4.7% while overall inflation sits at 1.2% and food and energy costs are easing. That mix reshapes household budgets and can shift where money flows across the service sector. For investors, it creates both potential winners and risks hiding in plain sight. This article walks through three large service sector stocks exposed to this inflation story and explains what their latest backdrop could mean for your watchlist. The three service sector stocks covered...

McCormick stock has had a difficult few years with the share price down 33.7% over three years, yet the broader valuation checks now suggest the stock does not look obviously expensive at current levels. McCormick shares have declined 33.7% over the past three years, which raises the question of whether expectations for the business were set too high or if the current price is starting to factor in more modest assumptions. Future pricing power and margin resilience in McCormick's core spices...

Doximity entered this earnings week as a quietly discounted healthcare platform with a P/E below many digital health peers. The stock is no longer quiet. Shares surged about 33% in the first full session after the Q1 2027 report as investors rushed to reprice a business that is pouring money into clinical artificial intelligence while still generating strong profits. The headline is simple: Doximity delivered roughly $157 million of revenue and a 48% adjusted earnings before interest, taxes,...

SK hynix stock has fallen 17.9% year to date, which puts the current share price under pressure just as investors are reassessing what they are willing to pay for its memory and AI exposure. The 17.9% year to date decline raises the question of whether recent weakness has moved SK hynix closer to a valuation floor or if it simply reflects a reset in expectations. The approved US$38b build out of two new memory chip plants can support long term revenue potential tied to AI demand. However,...

Ardelyx stock just dropped 17.9% to about US$4, extending a three month slide that has taken roughly 41% off the share price. The hit looks harsh when set against what the company just posted. Q2 product revenue reached US$118 million, led by irritable bowel syndrome with constipation drug IBSRELA at US$86.2 million. The company still reported a loss of US$16.7 million, although that was smaller than in Q1. For a biotech like Ardelyx, the real story now sits in the multi year revenue targets,...

Macy's stock has delivered a very strong 1 year return, yet the valuation work suggests the shares may still be trading at a discount to what the underlying cash flows imply. Over the past year, Macy's has returned 118.2%, which puts more focus on whether recent buyers are overpaying or still getting in below intrinsic value. The key support for the current price is the market's view on Macy's ability to keep converting its retail footprint into steady cash flows. Any sustained pressure on...

Venture Global has had a strong run so far this year, and current valuation checks suggest the stock now trades closer to fair than obviously cheap levels. The stock is up 88.4% year to date, which puts more pressure on current expectations to justify the move. The recent Baker Hughes liquefaction technology order can support long term project visibility, while execution risk on large scale LNG developments may still weigh on how investors price the stock. Venture Global scores highly on...

In late July 2026, TriNet Group, Inc. reported second-quarter revenue of US$1,178 million versus US$1,238 million a year earlier, while net income rose to US$53 million from US$37 million and diluted earnings per share from continuing operations increased to US$1.15 from US$0.77. Despite lower revenue for both the quarter and first half, TriNet converted more of its top line into profit and lifted full-year 2026 revenue guidance to US$4.75–US$4.9 billion and diluted net income per share...

Kohl's stock has delivered a 79.0% return over the past year, yet valuation checks still indicate the shares screen as undervalued on several measures. With that backdrop and a recent change in board leadership, investors are weighing whether the current price still reflects a discount to the fundamentals. The 79.0% 1 year return points to a strong rebound in sentiment, which can raise the bar for what counts as good value from here. The appointment of Wendy Arlin as board chair and Niren...

In the past quarter ended June 30, 2026, American Financial Group, Inc. reported second-quarter revenue of US$2,030 million and net income of US$248 million, with diluted earnings per share from continuing operations of US$2.99, alongside a six‑month revenue of US$3,884 million and net income of US$439 million. Over the same period, the company also continued its long-running capital return program, repurchasing 200,231 shares for US$26 million and bringing total buybacks under its 2010...

CF Industries Holdings just delivered one of the punchiest profit prints in the sector, yet the stock slipped about 2% on the day after earnings to around US$114. The market marked the price down. The earnings told a different story. Net income for the quarter landed at US$727 million with basic earnings per share of US$4.73, powered by what management frames as a new, higher mid cycle cash generation profile. Coming into the release, CF Industries Holdings had been treading water over the...

Patterson-UTI Energy, Inc. recently filed a US$296.803 million shelf registration for 28,900,000 common shares tied to an ESOP-related offering, and reported second-quarter 2026 sales of US$1,227.97 million with a net loss of US$19.6 million, narrower than a year earlier. The combination of improving analyst sentiment, upgraded full-year earnings estimates, and a smaller quarterly loss suggests investors are focusing on operational progress rather than headline losses alone. We’ll now...

Recent commentary on Bill Ackman’s Pershing Square (PS) portfolio, which concentrates seven stocks in about 98% of assets and includes Microsoft, Amazon, Uber and Meta Platforms, has drawn fresh attention to Pershing Square’s own listed shares. See our latest analysis for Pershing Square. Pershing Square’s share price return over the year has been strong, with a year to date share price return of 56.53% and a recent 7 day share price return of 13.82%. The 90 day share price return is down...

Procter & Gamble stock sits in an interesting spot right now. The Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable valuation gap, while the broader checks still flag only a mixed picture and the share price has delivered relatively modest gains over five years. Over the past 5 years, Procter & Gamble has returned 15.4%, which is a steady result rather than a runaway winner for long term holders. The planned US$3.8b acquisition of supplement brand Thorne may support...

KRR stock has fallen 27.5% over the past year but is still up 69.6% over three years, while valuation checks send mixed signals as the intrinsic value estimate suggests upside and earnings based multiples lean the other way. That split, set against a busy deal pipeline in infrastructure, energy and healthcare, is what current holders and potential buyers are trying to make sense of. KKR’s 69.6% gain over three years highlights how much of the long term value case has already been reflected...

Senseonics Holdings went into this report as a high growth, high expectation diabetes tech stock, and the market clearly liked what it saw. The share price jumped about 36% to US$7.02 the day after earnings, a big move for a medical device company still posting sizeable losses. The headline is simple: strong revenue traction in continuous glucose monitoring and a sharp lift in gross margin grabbed investors’ attention, even though Senseonics reported a net loss of US$36.7 million for the...

Brookfield Infrastructure Partners (NYSE:BIP) reported second quarter 2026 results with sales of US$6,482 million and a net loss of US$24 million, along with an affirmed quarterly distribution of US$0.455 per unit. See our latest analysis for Brookfield Infrastructure Partners. At a share price of US$39.04, Brookfield Infrastructure Partners has seen a 4.5% 1 month share price return and a 13.8% share price return year to date. The 1 year total shareholder return of 36.2% points to stronger...

Cactus has delivered a 104.5% return over the past five years, yet its current checks send mixed valuation signals, with the Discounted Cash Flow (DCF) estimate pointing to upside while earnings-based multiples point to a richer price tag. The 104.5% five year return sets a high bar for new buyers and raises the question of how much future performance is already reflected in the share price. Recent earnings strength can support higher expectations for cash generation, although any pressure...

Rapid money growth and fresh support from the Federal Reserve are flooding markets with liquidity, even as high policy rates remain in place. That mix can reward some large U.S. growth stocks and leave others exposed if conditions shift. This article walks through how those cross currents connect to three specific stocks from a U.S. Large Cap Growth Stocks screener, and why their exposure to these policy moves matters for your portfolio decisions today. The stocks covered below are just a...

NeoGenomics earnings shift puts Q2 profitability in focus NeoGenomics (NEO) returned to profitability in the second quarter of 2026, reporting net income of US$2.24 million on sales of US$201.66 million, compared with a net loss a year earlier. See our latest analysis for NeoGenomics. At a share price of US$16.57, NeoGenomics has seen strong momentum build over 2026, with a 90 day share price return of 84.93% and a 1 year total shareholder return of 185.69%. This reflects shifting...

Open Text came into this earnings print with a stock that had quietly climbed over the past month, then gave back ground as shares fell about 3% in the first session after results. The long term thesis centers on a cash generative software platform that pays investors a dividend and trades on a single digit P/E. The headline from this quarter is profit strength. Adjusted EBITDA margin sat in the mid 30s, free cash flow reached about US$808m for the year and net margin over the last twelve...